0009-7663 : Aromasin 25 mg Oral Tablet


NDC: 0009-7663
Labeler: Pharmacia and Upjohn Company
Product Type: Human Prescription Drug
Drug Name:  Aromasin
Dosage Form: Oral Tablet
Application #: NDA020753
Rev. Date: 


Appearance:


Markings: 7663
Shapes:  Round
Colors:  White
Size (mm): 6
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

7663: (0009-7663) Aromasin 25 mg Oral Tablet by Pharmacia and Upjohn Company
The above image is provided by the U.S. National Library of Medicine (NLM) and is not part of the official label.

NDC Package Codes:

  • 0009-7663-04: 30 TABLET IN 1 BOTTLE (0009‑7663‑04)

Active Ingredients:

  • Exemestane

Dosage Strength:

  • 25 mg

Inactive Ingredients:

  • Mannitol
  • Crospovidone
  • Polysorbate 80
  • Hypromelloses
  • Silicon Dioxide
  • Cellulose, Microcrystalline
  • Magnesium Stearate
  • Polyethylene Glycol 6000
  • Sucrose
  • Magnesium Carbonate
  • Titanium Dioxide
  • Methylparaben
  • Polyvinyl Alcohol

Pharmaceutical Classes:

  • Aromatase Inhibitor [EPC]
  • Aromatase Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 54868-5261 Aromasin 25 mg Oral Tablet by Physicians Total Care, Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 0009-7663 QR Code

< Prev: 0009-7529Next: 0009-7667 >

Related Discussions:

Exemestane side effects
I have been taking Exemestane for 2-1/2 months. My hands are numb and also tingling. The pain with the tingling is so ba... 1 reply
Is Exemestane made by Alvogen the same quality as Greenstone?
I have taken Exemestane made by Greenstone for two years. Now the pharmacy has switched to Exemestane made by Alvogen. A... 1 reply
Alvogen discontinuing Exemestane?
Why did Alvogen stop making Exemestane? I can no longer get this med as of Dec 2021. No one knows the reason and I calle...
intravenous formulation of exemestane
please give me ans for why exemestain intravenous formulation not available what problame occure for this formulaton...




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.